File:Overall survival in non-small lung cancer patients treated with modern immunotherapy in the first line for advanced or metastatic disease.jpg

Page contents not supported in other languages.
Daga Wikipedia, Insakulofidiya ta kyauta.

Overall_survival_in_non-small_lung_cancer_patients_treated_with_modern_immunotherapy_in_the_first_line_for_advanced_or_metastatic_disease.jpg ‎(pikisal 550 × 346, girman fayil: 96 KB, irin MIME: image/jpeg)

Wannan hoto yazo daga Wikimedia Commons kuma za'a iya amfani dashi a wasu projects. Anan kasa an nuna asalin bayanin shi

Taƙaici

Bayani
English: Comparison of over survival and hazard ratios (HR) in clinical trials incorporating immunotherapy in the first line for patients with non-small cell lung cancer. The treatment arms without and with immunotherapy are compared in KEYNOTE-024, KEYNOTE-042, KEYNOTE-189, KEYNOTE-407, CHECKMATE-227, CHECKMATE 9LA, IMpower110, IMpower130, and IMpower150.Nasser NJ, Gorenberg M, Agbarya A.Pharmaceuticals 2020, 13(11), 373; https://doi.org/10.3390/ph13110373
Rana
Masomi

First line Immunotherapy for Non-Small Cell Lung Cancer. Nasser NJ, Gorenberg M, Agbarya A.

Pharmaceuticals (Basel). 2020 Nov 8;13(11):373 https://doi.org/10.3390/ph13110373
Marubucin

Nicola J. Nasser, Miguel Gorenberg, Abed Agbarya.

Pharmaceuticals (Basel). 2020 Nov 8;13(11):373 https://doi.org/10.3390/ph13110373

Lasisi

w:en:Creative Commons
Jinginarwa
This file is licensed under the Creative Commons Attribution 4.0 International license.
Za ka iya:
  • a raba – dan kwafa, yadawa da aika aikin
  • dan maimaita – dan daukar aikin
A karkashin wannan sharuddan
  • Jinginarwa – Dole ku bada jinjina da ta dace, samar da linki zuwa lasisin, da kuma bayyana ko kunyi sauyi. Zaku iya haka ta yadda ta dace, amma ba kowace hanya ba wanda zai nuna mai-lasisin yana goyon bayan ku ba ko goyon bayan amfanin da kuke yi ba.

Take

Add a one-line explanation of what this file represents
Overall survival in phase III trials for non-small lung cancer patients treated with immunotherapy as first line

Abubuwan da aka nuna a cikin wannan fayil

depicts Turanci

copyright status Turanci

copyrighted Turanci

farawa

8 Nuwamba 2020

Tarihin fayil

Ku latsa rana/lokaci ku ga fayil yadda yake a wannan lokaci

Rana/LokaciWadar sufaKusurwowiMa'aikaciBahasi
na yanzu05:01, 10 Disamba 2020Wadar sufa ta zubin 05:01, 10 Disamba 2020550 × 346 (96 KB)SannecolaUploaded a work by Nicola J. Nasser, Miguel Gorenberg, Abed Agbarya. Pharmaceuticals (Basel). 2020 Nov 8;13(11):373 https://doi.org/10.3390/ph13110373 from First line Immunotherapy for Non-Small Cell Lung Cancer. Nasser NJ, Gorenberg M, Agbarya A. Pharmaceuticals (Basel). 2020 Nov 8;13(11):373 https://doi.org/10.3390/ph13110373 with UploadWizard

Wadannan shafi na amfani wannan fayil:

Amfanin fayil a ko'ina

Wadannan sauran wikis suna amfani da fayil din anan

Daga "https://ha.wikipedia.org/wiki/File:Overall_survival_in_non-small_lung_cancer_patients_treated_with_modern_immunotherapy_in_the_first_line_for_advanced_or_metastatic_disease.jpg"